Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: Role of D-alanine racemase

Journal of Proteome Research

Volumn 6, Issue 12, 2007, Pages 4608-4614

  Halouska, Steven ^a   Chacon, Ofelia ^a,b   Fenton, Robert J ^a   Zinniel, Denise K ^a   Barletta, Raul G ^a   Powers, Robert ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b Corporacion para Las Investigaciones Biologicas ^*  (Colombia)

Author keywords

D alanine racemase; D cycloserine; Metabolomics; Mycobacterium smegmatis; NMR; Principal component analysis; Tuberculosis

Indexed keywords

ALANINE RACEMASE; CYCLOSERINE; DEXTRO ALANINE; PEPTIDOGLYCAN;

ARTICLE; BACTERIAL GROWTH; BIOSYNTHESIS; CELL WALL; CONTROLLED STUDY; METABOLOMICS; MYCOBACTERIUM; NONHUMAN; OSMOTIC PRESSURE; POLYMERIZATION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN TARGETING; PROTON NUCLEAR MAGNETIC RESONANCE; PYRIMIDINE METABOLISM;

ALANINE; ALANINE RACEMASE; ANTIBIOTICS, ANTITUBERCULAR; CYCLOSERINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MAGNETIC RESONANCE SPECTROSCOPY; MYCOBACTERIUM SMEGMATIS; PEPTIDOGLYCAN; PROTEOME;

CORYNEBACTERINEAE; MYCOBACTERIUM SMEGMATIS;

EID: 38049041308     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0704332     Document Type: Article

References (50)

1. W.H.O. Global Tuberculosis Control: Surveillance, Planning and Financing;WHO/HTM/TB/2007.376; World Health Organization: Geneva, Switzerland, 2007.
2. Rattan, A.; Kalia, A.; Ahmad, N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerging Infect. Dis. 1998, 4 (2), 195-209.
3. Williams, B. G.; Dye, C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 2003, 301 (5639), 1535-1537.
4. Telenti, A. Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis. Thorax 1998, 53 (9), 793-797.
5. Dooley, S. W.; Jarvis, W. R.; Martone, W. J.; Snyder, D. E. J. Multidrug resistant tuberculosis [editorial]. Ann. Intern. Med. 1992, 117, 257-258.
6. Iseman, M. D. Treatment and implications of multidrug-resistant tuberculosis for the 21st century. Chemotherapy (Basel) 1999, 45 (2), 34-40.
7. Barry, C. E., III. Modern drug development. Issues Infect. Dis. 2003, 2 (Mycobacteria and TB), 137-150.
8. Gillespie, S. H. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 2002, 46 (2), 267-274.
9. Hyman, C. L. Tuberculosis: a survey and review of current literature. Curr. Opin. Pulm. Med. 1995, 1 (3), 234-242.
10. Udwadia, Z. F. India's multidrug-resistant tuberculosis crisis. Ann. N.Y. Acad. Sci. 2001, 953, 98-105.
11. Anonymous. Tuberculosis crisis. World Health Forum 1994,l5 (3), 292-293.
12. Joshi, J. M.; Gothi, D. Multi-drug resistant pulmonary tuberculosis. Curr. Respir. Medicine Rev. 2006, 2 (1), 53-57.
13. Johnson, R.; Streicher, E. M.; Louw, G. E.; Warren, R. M.; van Helden, P. D.; Victor, T. C. Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 2006, 8 (2), 97-111.
14. Pitkanen, M.; Sirvio, J.; MacDonald, E.; Ekonsalo, T.; Riekkinen, P., Sr. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats. J. Neural Transm. 1995, 9 (2-3), 133-144.
15. Ramaswamy, S.; Musser, J. M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 1998, 79L (1), 3-29.
16. Feng, Z.; Barletta, R. G. Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine. Antimicrob. Agents Chemother. 2003, 47 (1), 283-291.
17. Lambert, M. P.; Neuhaus, F. C. Mechanism of D-cycloserine action. Alanine racemase from Escherichia coli W. J. Bacteriol. 1972, 110 (3), 978-087.
18. David, H. L.; Takayama, K.; Goldman, D. S. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. Am. Rev. Respir. Dis. 1969, 100 (4), 579-581.
19. Caceres, N. E.; Harris, N. B.; Wellehan, J. F.; Feng, Z.; Kapur, V.; Barletta, R. G. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J. Bacteriol. 1997, 119 (16), 5046-5055.
20. Zhang, Y. The magic bullets and tuberculosis drug targets. Ann. Rev. Pharmacol. Toxicol. 2005, 45, 529-564.
21. Chacon, O.; Feng, Z.; Harris, N. B.; Caceres, N. E.; Adams, L. G.; Barletta, R. G. Mycobacterium smegmatisD-alanine racemase mutants are not dependent on D-alanine for growth. Antimicrob. Agents Chemother. 2002, 46 (1), 47-54.
22. Forgue, P.; Halouska, S.; Werth, M.; Xu, K.; Harris, S.; Powers, R. NMR Metabolic profiling of Aspergillus nidulans to monitor drug and protein activity. J. Proteome Res. 2006, 5 (8), 1916-1923.
23. Goodacre, R.; Vaidyanathan, S.; Dunn, W. B.; Harrigan, G. G.; Kell, D. B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004, 22 (5), 245-252.
24. Kell, D. B. Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol. 2004, 7 (3), 296-307.
25. Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Fund. Genomics 2001, 2 (3), 155-168.
26. Bollard, M. E.; Stanley, E. G.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005, 18 (3), 143-162.
27. Ward, J. L.; Beale, M. H. NMR spectroscopy in plant metabolomics. Biotechnol. Agric. For. 2006, 57, 81-91 (Plant Metabolomics).
28. Pan, Z.; Raftery, D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal. Bioanal. Chem. 2007, 387 (2), 525-527.
29. Griffin, J. L. The potential of metabonomics in drug safety and toxicology. Drug Discovery Today: Technol. 2004, 1 (3), 285-293.
30. Stoyanova, R.; Brown, T. R. NMR spectral quantitation by principal component analysis. NMR Biomed. 2001, 14 (4), 271-277.
31. Snapper, S. B.; Melton, R. E.; Mustafa, S.; Kieser, T.; Jacobs, W. R., Jr. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 1990, 4 (11), 1911-1919.
32. Halouska, S.; Powers, R. Negative impact of noise on the principal component analysis of NMR data. J. Magn. Reson. 2006, 118 (1), 88-95.
33. Van Heijenoort, J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001, 11 (3), 25R-36R.
34. Trias, J.; Benz, R. Permeability of the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 1994, 14 (2), 283-290.
35. Nanninga, N. Morphogenesis of Escherichia coli. Microb. Mol. Biol. Rev. 1998, 62 (1), 110-129.
36. Mahapatra, S.; Scherman, H.; Brennan, P. J.; Crick, D. C. N glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J. Bacteriol. 2005, 187 (7), 2341-2347.
37. van Heijenoort, J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat. Prod. Rep. 2001, 18 (5), 503-519.
38. Scheffers, D.-J.; Pinho, M. G. Bacterial cell wall synthesis: new insights from localization studies. Microb. Mol. Biol. Rev. 2005, 69 (4), 585-607.
39. Denessiouk, K. A.; Denesyuk, A. I.; Lehtonen, J. V.; Korpela, T.; Johnson, M. S. Common structural elements in the architecture of the cofactor-binding domains in unrelated families of pyridoxal phosphate-dependent enzymes. Proteins: Struct., Funct., Genet. 1999, 35 (2), 250-261.
40. Noda, M.; Kawahara, Y.; Ichikawa, A.; Matoba, Y.; Matsuo, H.; Lee, D.-G.; Kumagai, T.; Sugiyama, M. Self-protection mechanism in D-cycloserine- producing Streptomyces lavendulae. Gene cloning, characterization, and kinetics of its alanine racemase and D-alanyl-D-alanine ligase, which are target enzymes of D-cycloserine. J. Biol. Chem. 2004, 279 (44), 46143-46152.
41. Lilley, P. E.; Stamford, N. P. J.; Vasudevan, S. G.; Dixon, N. E. The 92-min region of the Escherichia coli chromosome: Location and cloning of the ubiA and alr genes. Gene 1993, 129 (1), 9-16.
42. Wild, J.; Hennig, J.; Lobocka, M.; Walczak, W.; Klopotowski, T. Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12. Mol. Gen. Genet. 1985, 198 (2), 315-322.
43. Hols, P.; Defrenne, C.; Ferain, T.; Derzelle, S.; Delplace, B.; Delcour, J. The alanine racemase gene is essential for growth of Lactobacillus plantarum. J. Bacteriol. 1997, 119 (11), 3804-3807.
44. Margolin, W. Bacterial shape: Growing off this mortal coil. Curr. Biol. 2003, 13 (18), R705-R707.
45. Lundberg, P.; Vogel, T.; Malusek, A.; Lundquist, P.-O.; Cohen, L.; Dahlqvist, O. MDL - The Magnetic Resonance Metabolomics Database, mdl.imv.liu.se.
46. Seavey, B. R.; Farr, E. A.; Westler, W. M.; Markley, J. L. A relational database for sequence-specific protein NMR data. J. Biomol. NMR 1991, 1, 217-236.
47. Wishart, D. S. HMDB: the human metabolome database. Nucleic Acids Res. 2007, 35, D521-D526.
48. Ellsworth, B. A.; Tom, N. J.; Bartlett, P. A. Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. Chem. Biol. 1996, 3 (1), 37-44.
49. Strych, U.; Penland, R. L.; Jimenez, M.; Krause, K. L.; Benedik, M. J. Characterization of the alanine racemases from two Mycobacteria. FEMS Microb. Lett. 2001, 196 (2), 93-98.
50. Berberich, R.; Kaback, M.; Freese, E. D-Amino acids as inducers of L-alanine dehydrogenase in Bacillus subtilis. J. Biol. Chem. 1968, 243 (5), 1008-1013.